German-based pizza maker Dr Oetker said it experienced a mixed performance in 2019 across its European operations, with its home country seeing a significant increase in sales.
The group attributed product innovations and a streamlining of its product range to its solid performance there.
The company’s pizza category had great success in the UK, Norway, Finland, and Spain, but these were offset by poor performances in key markets such as Italy.
Investment
Last year, the group invested up to €149 million in its operations across the board, with just €26 million being invested in its home market.
The group began the construction of a new administrative building in Wittlich, which is due to be completed this year.
The group also built new facilities in South Africa, Poland and Russia, as well as a new warehouse in Romania.
In 2015, the group acquired Conditorei Coppenrath & Wiese, which was incorporated into Dr Oetker’s results for the first time last year.
Albert Christmann, Dr Oetker chairman said, "Dr Oetker and Conditorei Coppenrath & Wiese will continue its growth and expansion strategy in line with its strategy and, in addition, seize the opportunities offered by a changing world.”
"We will continue to develop and bring to the market innovative products and services for consumers. The same applies to new, also digital business models, which we will test and, where appropriate, introduce nationally and internationally.
“In addition, we will gradually simplify and standardise our internal structures in order to counter the growing complexity of our business," he added.
© 2019 Checkout – your source for the latest Irish retail news. Article by Aidan O’Sullivan. Click sign-up to subscribe to Checkout.
